JAK2 siRNA (r) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

JAK2 siRNA (r)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
JAK2 siRNA (r)

Product Specs
ItemJAK2 siRNA (r)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-270385
Quantity10 µM
Speciesrat
NCBI Full Gene NameJanus kinase 2
NCBI Gene AliasesFd17, JTK10
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The JAK2/STAT3 signaling pathway is required for inflammation and cell death induced by cerulein in AR42J cellsEuropean review for medical and pharmacological sciencesFebruary 1, 2019Chen WD, Zhang JL, Wang XY, Hu ZW, Qian YB.

(2) Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in ratsMolecular medicine reportsAugust 1, 2018Song D, Liu X, Diao Y, Sun Y, Gao G, Zhang T, Chen K, Pei L.Cell transfection H9C2 cells were transfected with a plasmid containing JAK2 small interfering (si)RNA (10 µM, sc-270385, Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and then seeded into 6-well culture plates at a density

(3) IL-5 blocks apoptosis and tau hyperphosphorylation induced by Aβ(25-35) peptide in PC12 cellsJournal of physiology and biochemistryMay 1, 2017Zhou Y, Li C, Li D, Zheng Y, Wang J.

(4) Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stressActa pharmacologica SinicaMarch 1, 2016Zhao GL, Yu LM, Gao WL, Duan WX, Jiang B, Liu XD, Zhang B, Liu ZH, Zhai ME, Jin ZX, et al.

(5) MicroRNA-101 inhibits proliferation of pulmonary microvascular endothelial cells in a rat model of hepatopulmonary syndrome by targeting the JAK2/STAT3 signaling pathwayMolecular medicine reportsDecember 1, 2015Wang L, Zhuang L, Rong H, Guo Y, Ling X, Wang R, Yu X, Zhang W.

Be the First to Write a Review!